Author Archives: Natalie Themm
Myriad Genetics Teams Up with Epic to Make Genetic Testing Accessible to More Patients with Electronic Health Record (EHR) Integration
Healthcare providers can easily order Myriad’s genetic tests for the more than 250 million patients within Epic’s network
U.S. Patent Office Grants New Patent Protection For Exoskeleton Focal-Force Angioplasty Platform
Transit Scientific achieved increased U.S. patent protection for their novel exoskeleton focal-force angioplasty technology using standard off-the-shelf peripheral transluminal angioplasty (PTA) balloons.
CenExel Acquires Apex Innovative Sciences
Premier CNS-Focused Research Facilities in California and New Jersey Join the CenExel Centers of Excellence Clinical Research Site Network
Sen. Romney Opposes Drug Importation as the Senate HELP Committee Advances User Fees
The Senate Health, Education, Labor and Pensions (HELP) Committee voted 13 to 9 on Tuesday to advance user fee reauthorization legislation.
Halia Therapeutics Announces First Participant Dosed in Phase 1 Clinical Study of HT-6184
HT-6184 is a novel NEK7/NLRP3 inhibitor
BD Collaborates with Mayo Clinic Platform, Leveraging Real-World Clinical Data to Improve Post-Market Device Surveillance, Drive Innovation for Patient Care
BD is among the first companies to enter innovative partnership with Mayo Clinic Platform for access to world’s largest collection of clinical data
CerTest Biotec and BD Announce Collaboration on Molecular Diagnostic Test for Monkeypox
CerTest Biotec Uses the BD MAX™ Molecular Diagnostic System Open System Reagent Suite to Develop RT-PCR Detection Kit
BD TO ACQUIRE PARATA SYSTEMS TO ENTER NEW PHARMACY AUTOMATION SOLUTIONS MARKET
Expands BD Transformative Solutions to Provide New Pharmacy Automation Technologies for Hospitals, Retail Pharmacy, Long-Term Care and Home Settings Advances BD 2025 Strategy to Accelerate Innovation in Smart, Connected Care and Enable New Care Settings Expected to be Immediately Accretive to Revenue Growth, Adjusted Operating Margins and Adjusted EPS; Enhances Ability to Achieve Long-Range Sales […]
KidneyIntelX™ Demonstrates Ability to Assess Risk of Heart Failure Hospitalization and Death in Large International Diabetic Kidney Disease Patient Cohort
Data shared in oral presentation at American Diabetes Association 82nd Scientific Sessions® and published in Kidney360 highlights importance in early understanding of cardiovascular risk, a leading cause of death in patients with diabetes and chronic kidney disease
PolarityTE Announces $8.0 Million Registered Direct and Private Placement Offerings Priced At-The-Market Under Nasdaq Rules
PolarityTE announced that it has entered into securities purchase agreements with a single healthcare-focused institutional investor
Civica Selects Profil as Clinical Trial Partner for Affordable Insulin Initiative
Profil has conducted over 30 biosimilar insulin trials and is the leading clinical research organization for studies related to diabetes.
Biomerics announces expansion in Ireland with a new facility in Galway
BIOMERICS ANNOUNCES EXPANSION INTO IRELAND Expanding High-Performance Balloon Design & Development Capabilities in Galway
